Spire Wealth Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Spire Wealth Management's HALO Position: Q2 2026 in Review
Spire Wealth Management reduced its Halozyme (HALO) stake by 3.3% in Q2 2026, selling an estimated $16.8K and leaving 7,144 shares worth $559K. The position accounts for 0.02% of the portfolio, ranked #532.
Spire Wealth Management first reported a position in HALO in Q1 2021 and has held it in 20 quarters since. The position peaked at $7.18M in Q2 2022. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Spire Wealth Management held 7,144 shares of Halozyme worth $559K as of Q2 2026.
- Spire Wealth Management sold 247 Halozyme shares in Q2 2026, an estimated $16.8K.
- Halozyme made up 0.02% of Spire Wealth Management's portfolio in Q2 2026, its #532 holding.
- Spire Wealth Management first reported a position in Halozyme in Q1 2021 and has held it in 20 quarters since.
- Spire Wealth Management's Halozyme position peaked at $7.18M in Q2 2022.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.